Front Page
May 4, 2026
Northwest ATTC Webinar: Direct to Inject (Buprenorphine) Strategies to Improve Care for People with SUD and Infectious Disease (May 20, 12pm PT)
Join the Northwest ATTC on May 20, 2026 (12-1pm PT) for their next webinar: Syndemic Care for People Struggling with Substance Use Disorder (SUD) – Leveraging Direct to Inject (DTI) Strategies to Improve Care Integration Presenter: Chris Bositis, MD, Clinical Director, UCSF National Clinician Consultation Center (NCCC) In spite of recent gains made in reducing new…
May 1, 2026
The Northwest ATTC at ADAI is Hiring! Continuing Education Specialist 4 (80% FTE, fully remote)
Come join our awesome team and help the Northwest Addiction Technology Transfer Center (Northwest ATTC) help others in the addiction workforce! The Northwest ATTC is seeking a Continuing Education Specialist 4 (80% FTE, pay range $81,780-$122,676). This is a FULLY REMOTE position that may include the opportunity for some travel. Minimum requirements include a Master’s degree and 3 years of…
April 23, 2026
ADAI/CEDEER Virtual Conference: Supporting the Health of People Who Use Drugs, June 2-3, 2026
Join ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) to learn more about practical strategies and programs that support the health of people who use drugs in Washington State. Topics for this event include: We hope you can join us online to converse and connect! Register here!
April 16, 2026
RECORDING AVAILABLE: Results from the 2025 WA State Syringe Services Program Health Survey – Report and Webinar
The WA State Syringe Services Program Health Survey is conducted every other year by CEDEER at UW ADAI in partnership with Public Health-Seattle & King County, the Washington State Department of Health, and syringe services programs (SSPs) across the state. The surveys asks participants about their substance use, health behaviors, and health care and substance use treatment needs….
April 7, 2026
ADAI Lunch & Learn: Motivated Cannabis Compliance: Using Retail Incentives to Sell Safety (April 30, 12pm PT)
In this month’s ADAI Lunch & Learn, Sarah Okey, PhD, Research Psychologist & Research Program Manager at the WA State Liquor and Cannabis Board, will showcase how the retail point-of-sale is one of the most critical interventions for consumer safety. Over 90% of adults who buy cannabis at Washington retail stores ask staff questions about what…
Upcoming Trainings: Two Depressants, One Conversation: Addressing Alcohol Use Among People with OUD (April/May 2026)
Alcohol use is common among people who use opioids, including fentanyl. Alcohol worsens health, complicates treatment, and increases overdose risk. The good news? There are ways to help people cut back on their alcohol use. Join CEDEER’s Washington State Opioid Response Training Team for a training focusing on practical, evidence based approaches to alcohol withdrawal,…
April 1, 2026
RECORDING AVAILABLE: CEDEER Webinar: Harm Reduction in All Directions: Supporting the Workforce
Update: This event was held on March 31, 2026. The slides & recording are now available. Harm reduction program staff serve an essential role in improving the health of people who use drugs. As front-line workers and first responders, they bring unique expertise and community connection to their work. However, their strengths and specialized needs…
March 30, 2026
New ADAI Research: Cannabis-Related Problems, Adverse Events, Clinical Experiences, and Barriers to Intervening for Health Care Providers in WA State
Citation: Carlini BH, Kellum LB, Garrett SB, Williams JR. Cannabis-related problems, adverse events, clinical experiences and barriers to intervening: Perspectives of health care providers in Washington State. Substance Use & Addiction 2026 (in press). doi: 10.1177/29767342261426116 This new paper from ADAI’s Cannabis Education & Research Program (CERP) team (CERP Director Beatriz Carlini and Lyndsey Kellum,…
March 11, 2026
New from ADAI: Fentanyl, Meth Use Impact Behavior in Rats; Psychedelic Treatment Reverses Social Deficits
Drug overdose deaths in the United States have skyrocketed over the last 20 years, and an increasing number of those deaths now involve people using multiple substances, particularly opioids and stimulants. Despite how common this combination has become, most research has looked at these substances separately, leaving a major gap in our understanding of what…
March 10, 2026
CEDEER/SOR Webinar: What’s the Latest? Psychedelics for Opioid Use Disorder (March 30, 12pm PT)
Interest in the therapeutic use of psychedelics has grown rapidly in recent years—but what does the emerging research indicate about their role in treating opioid use disorder (OUD)? In this session, presented by Nathan Sackett, MD, MS, of ADAI’s Center for Novel Therapeutics in Addiction Psychiatry, we’ll explore the current evidence, potential mechanisms, safety considerations,…
Next page
